Enfusion's general counsel Matthew Campobasso sells $9,886 in stock

Published 10/01/2025, 22:20
Enfusion's general counsel Matthew Campobasso sells $9,886 in stock

Matthew Campobasso, General Counsel at Enfusion, Inc. (NYSE:ENFN), recently sold 976 shares of the company's Class A Common Stock. The shares were sold on January 7 at a weighted average price of $10.13, amounting to a total transaction value of $9,886. The stock, which has gained nearly 23% over the past six months, currently trades near InvestingPro's Fair Value estimate. With a market capitalization of $1.3 billion and strong liquidity metrics, including a current ratio of 3.6, the company maintains a solid financial position. Following this sale, Campobasso retains ownership of 52,651 shares. The transaction was conducted to cover tax withholding obligations related to the issuance of shares, as noted in the filing. InvestingPro analysis reveals the company operates with moderate debt levels and maintains healthy financial metrics. Subscribers can access 10 additional ProTips and a comprehensive Pro Research Report, offering deeper insights into ENFN's valuation and growth prospects.

In other recent news, Enfusion Inc. reported a robust Q3 growth marked by a 15% increase in year-over-year revenue, reaching $51.2 million. The company's adjusted EBITDA stood at $11.1 million, signifying a 21.8% margin. Enfusion's annual recurring revenue surpassed $200 million, a 14% increase year-over-year. Additionally, the net dollar retention rate remained steady at 102%.

The company signed 38 new clients, bringing the total to 894, and reported an average total value of $229,000, up by 5.7% year-over-year. Revenue growth was notable across all regions, with the Americas, EMEA, and Asia-Pacific seeing increases of 17%, 22%, and 6% respectively.

Enfusion has updated its full-year revenue guidance to between $202 million and $205 million, with EBITDA guidance at $41 million to $45 million. The company's management expressed confidence in achieving its medium-term revenue growth target of 20% to 22% from 2025 to 2027. These are among the recent developments concerning the company's financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.